| Target Price | €641.00 |
| Price | €344.00 |
| Potential |
86.34%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Limes Schlosskliniken price target 2026.
The average Limes Schlosskliniken target price is €641.00.
This is
86.34%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Limes Schlosskliniken to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Limes Schlosskliniken stock has an average upside potential 2026 of
86.34%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 38.12 | 50.00 |
| 0.42% | 31.15% | |
| EBITDA Margin | 18.49% | 28.21% |
| 8.47% | 52.53% | |
| Net Margin | 8.16% | 11.28% |
| 8.91% | 38.26% |
2 Analysts have issued a sales forecast Limes Schlosskliniken 2025 . The average Limes Schlosskliniken sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Limes Schlosskliniken EBITDA forecast 2025. The average Limes Schlosskliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Limes Schlosskliniken Analysts have issued a net profit forecast 2025. The average Limes Schlosskliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 10.61 | 19.45 |
| 8.38% | 83.32% | |
| P/E | 17.68 | |
| EV/Sales | 2.09 |
2 Analysts have issued a Limes Schlosskliniken forecast for earnings per share. The average Limes Schlosskliniken EPS is
This results in the following potential growth metrics and future valuations:
Limes Schlosskliniken...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


